Showing results (271-280 of 372) with videos related to
Sort By:
Pageof 38
Blood|April 15, 1995
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphomaL Pasqualucci, M Wasik, B A Teicher, et al.Academia Oncology|August 5, 2025
Targeted therapy combinations with ipatasertib in multi-cell type 3D tumor spheroid modelsBeverly A Teicher, Naoko Takebe, Thomas S Dexheimer, et al.Cancer Research|December 15, 1995
DNA topoisomerase II alpha expression is associated with alkylating agent resistanceJ P Eder, V T Chan, S W Ng, et al.International Journal of Oncology|February 13, 2009
Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markersRebecca G Bagley, William Weber, Cecile Rouleau, et al.Biochemical Pharmacology|March 8, 1996
Effect of DNA conformation on cisplatin adduct formationG J Bubley, J Xu, N Kupiec, et al.Cancer Chemotherapy and Pharmacology|November 1, 2003
LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing miceKristan A Keyes, Larry Mann, Michael Sherman, et al.British Journal of Cancer|June 9, 1999
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatinB Cenni, H K Kim, G J Bubley, et al.Cancer Research|November 15, 1989
Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistanceY Y Wang, B A Teicher, T C Shea, et al.Cancer Research|February 15, 1991
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinomaB A Teicher, T S Herman, J Tanaka, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 1993
Local hyperthermia, radiation therapy, and chemotherapy in patients with local-regional recurrence of breast carcinomaB A Bornstein, P S Zouranjian, J L Hansen, et al.Pageof 38